Induction and consolidation therapy with Iparomlimab and Tuvonralimab for locally advanced esophageal squamous cell carcinoma: a prospective, single-arm, phase II study

Authors
Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2026
This article has no abstract
Epistemonikos ID: 0de1ae4d03eda72bbfb5345daaba45029875f3ec
First added on: Oct 10, 2026